NCT06417424

Brief Summary

This is a prospective, randomized, double-blind controlled trial. Elderly patients with constipation requiring colonoscopy were randomly divided into four groups: 1. Received both gastrointestinal external stimulation and transcutaneouselectrical acupoint stimulation; 2. Received gastrointestinal external stimulation singly; 3. Received transcutaneouselectrical acupoint stimulation singly; 4. No stimulation was given. All groups received oral administration of polyethylene glycol for intestinal cleansing. Boston Bowel Preparation Scale (BBPS) score was used to assess the quality of intestinal cleanliness , with a total score of 9, and higher scores indicating better intestinal cleanliness, and BBPS≥6 was defined effective.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 30, 2024

Completed
2 days until next milestone

Study Start

First participant enrolled

February 1, 2024

Completed
4 months until next milestone

First Posted

Study publicly available on registry

May 16, 2024

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2025

Completed
Last Updated

May 16, 2024

Status Verified

May 1, 2024

Enrollment Period

1.2 years

First QC Date

January 30, 2024

Last Update Submit

May 12, 2024

Conditions

Keywords

ntestine cleanlinesssenile constipation patientsGastrointestinal External Stimula

Outcome Measures

Primary Outcomes (2)

  • Boston Bowel Preparation Scale (BBPS)

    Boston Bowel Preparation Scale (BBPS) score was used to assess the quality of intestinal cleanliness , with a total score of 9, and higher scores indicating better intestinal cleanliness, and BBPS≥6 was defined effective.

    1 year

  • The positive rate of intestinal diseases

    The positive rate of intestinal diseases including polyps, adenoma, adenocarcinoma, enteritis, inflammatory bowel disease,diverticulum and so on by electronic colonoscopy.

    1 year

Secondary Outcomes (4)

  • Adverse reactions

    1 year

  • Willingness to repeat

    1 year

  • Gut microbiome alterations

    1 year

  • Gastrointestinal hormone

    1 year

Study Arms (4)

experimental group 1

EXPERIMENTAL

Received both gastrointestinal external stimulation and transcutaneouselectrical acupoint stimulation for 3 days, and then oral administration of polyethylene glycol for intestinal cleansing.

Device: gastrointestinal external stimulation

experimental group 2

EXPERIMENTAL

Received gastrointestinal external stimulation singly, and then oral administration of polyethylene glycol for intestinal cleansing.

Device: gastrointestinal external stimulation

experimental group 3

EXPERIMENTAL

Received transcutaneouselectrical acupoint stimulation singly, and then oral administration of polyethylene glycol for intestinal cleansing.

Device: gastrointestinal external stimulation

Control

NO INTERVENTION

No stimulation was given. Oral administration of polyethylene glycol for intestinal cleansing.

Interventions

We used the device Gastrointestinal multifunctional therapeutic instrument. The positive pole was placed 1 to 2cm above the umbilicus, and the negative pole was placed 4 to 10 cm to the right of the midpoint between the xiphoid process and the umbilicus.

experimental group 1experimental group 2experimental group 3

Eligibility Criteria

Age60 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 60-80 years old;
  • Colonoscopy was planned;
  • The diagnosis of constipation was in accordance with Rome Ⅳ criteria.

You may not qualify if:

  • Acute myocardial infarction (within 6 months), severe heart failure (New York Heart Association class II-V, chronic renal failure (CKD stage II-V), or mental disorder;
  • Colorectal resection;
  • Drugs of aspirin, warfarin, or other anticoagulants, and coagulopathy;
  • Oral administration any drugs that may affect gastrointestinal motility, such as proton pump inhibitors, non-steroidal anti-inflammatory drugs or antibiotics (within 4 weeks), probiotics (within 2 weeks);
  • The following diseases:inflammatory bowel disease, frequent diarrhea, severe gastroparesis, intestinal perforation or obstruction;
  • Participating in other clinical trials.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shanghai easthospital

Shanghai, Pudong New Area, 200120, China

RECRUITING

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The Participants, investigators and outcomes Assessor don't know receiverd which intervention, only care Providers know it.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: 1\. Received both gastrointestinal external stimulation and transcutaneouselectrical acupoint stimulation; 2. Received gastrointestinal external stimulation singly; 3. Received transcutaneouselectrical acupoint stimulation singly; 4. No stimulation was given. All groups received oral administration of polyethylene glycol for intestinal cleansing.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 30, 2024

First Posted

May 16, 2024

Study Start

February 1, 2024

Primary Completion

March 31, 2025

Study Completion

May 31, 2025

Last Updated

May 16, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will share

Locations